SU1697756A1 - Method for treating laryngeal diseases with persistent nonclosure of vocal folds - Google Patents
Method for treating laryngeal diseases with persistent nonclosure of vocal folds Download PDFInfo
- Publication number
- SU1697756A1 SU1697756A1 SU884445103A SU4445103A SU1697756A1 SU 1697756 A1 SU1697756 A1 SU 1697756A1 SU 884445103 A SU884445103 A SU 884445103A SU 4445103 A SU4445103 A SU 4445103A SU 1697756 A1 SU1697756 A1 SU 1697756A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- persistent
- nonclosure
- vocal folds
- treating laryngeal
- vocal
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Изобретение относитс к медицине, а именно к отоларингологии. Цель изобретени - предупреждение рецидивов. В качестве полимера субмукозно в голосовую складку ввод т 3%-ный полиакри-амидный гель. Преимуществом способа вл етс отсутствие воспалительной реакции в области иньекции и отсутствие миграции введенного препарата, что позвол ет получить стойкий эффект.The invention relates to medicine, namely to otolaryngology. The purpose of the invention is to prevent recurrences. As a submucous polymer, a 3% polyacryamide gel is introduced into the vocal fold. The advantage of this method is the absence of an inflammatory reaction in the area of injection and the absence of migration of the administered preparation, which allows to obtain a lasting effect.
Description
(S(S
СWITH
Изобретение относитс к медицине, а именно к отоларингологии.The invention relates to medicine, namely to otolaryngology.
Цель изобретени - предупреждение рецидивов.The purpose of the invention is to prevent recurrences.
Способ выполн ют следующим образом .The method is performed as follows.
Субмукозно в голосовые св зки ввод т 3%-ный полиа риламидный гель до восполнени недостающих объемов.A 3% polyamide gel was added to the vocal cords submucous before filling the missing volumes.
Пример. Б-на , Р-на О.А., 53 лет. Диагноз: паралич правой половины гортани . Субмукозно в среднюю треть правой голосовой складки введено 1,0 3%-ного ПА- АГ. Воспалительна реакци в послеоперационном периоде практически отсутствовала. Размер голосовой щели уменьшилс . По вилс сиплый голос средней звучности.Example. Б-на, Р-на О.А., 53 years. Diagnosis: paralysis of the right half of the larynx. Submucous in the middle third of the right vocal fold was introduced 1.0 3% PA-AG. The inflammatory response in the postoperative period was practically absent. The size of the glottis has decreased. By willows hoarse voice of medium sonority.
Преимущество предлагаемого способа состоит в том, что отсутствие воспалительной реакции и миграции введенного препарата позвол ет получить стойкий функциональный эффект и предупредить рецидивы.The advantage of the proposed method is that the absence of an inflammatory reaction and the migration of the administered preparation allows to obtain a stable functional effect and prevent relapses.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU884445103A SU1697756A1 (en) | 1988-06-20 | 1988-06-20 | Method for treating laryngeal diseases with persistent nonclosure of vocal folds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU884445103A SU1697756A1 (en) | 1988-06-20 | 1988-06-20 | Method for treating laryngeal diseases with persistent nonclosure of vocal folds |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1697756A1 true SU1697756A1 (en) | 1991-12-15 |
Family
ID=21383218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU884445103A SU1697756A1 (en) | 1988-06-20 | 1988-06-20 | Method for treating laryngeal diseases with persistent nonclosure of vocal folds |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1697756A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0742022A4 (en) * | 1994-08-10 | 1996-11-25 | Maloe Vnedrencheskoe Predpr In | Biologically compatible hydrogel |
US7186419B2 (en) | 2000-08-25 | 2007-03-06 | Contura Sa | Polyacrylamide hydrogel for arthritis |
US7678146B2 (en) | 2000-08-25 | 2010-03-16 | Contura A/S | Polyacrylamide hydrogel and its use as an endoprosthesis |
-
1988
- 1988-06-20 SU SU884445103A patent/SU1697756A1/en active
Non-Patent Citations (1)
Title |
---|
Авторское свидетельство СССР № 1055485, кл. А 61 В 17/00, 1988. * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0742022A4 (en) * | 1994-08-10 | 1996-11-25 | Maloe Vnedrencheskoe Predpr In | Biologically compatible hydrogel |
USRE38913E1 (en) | 1994-08-10 | 2005-12-06 | Contura Sa | Biocompatible hydrogel |
US7186419B2 (en) | 2000-08-25 | 2007-03-06 | Contura Sa | Polyacrylamide hydrogel for arthritis |
US7678146B2 (en) | 2000-08-25 | 2010-03-16 | Contura A/S | Polyacrylamide hydrogel and its use as an endoprosthesis |
US7780958B2 (en) | 2000-08-25 | 2010-08-24 | Contura Sa | Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflux |
US7790194B2 (en) | 2000-08-25 | 2010-09-07 | Contura A/S | Polyacrylamide hydrogel as a soft tissue filler endoprosthesis |
US8216561B2 (en) | 2000-08-25 | 2012-07-10 | Contura A/S | Polyacrylamide hydrogel for the treatment of incontinence and vesicouretal reflex |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1748644A3 (en) | Method for synthesis of azacycloalkane derivatives | |
RU2190594C2 (en) | Organic nitrates and pharmaceutical composition showing activity inhibiting platelet aggregation based on thereof | |
Makino et al. | Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I. | |
KR850007559A (en) | Implantable Formulations of Regulatory Peptides | |
KR900018129A (en) | Sulphoamino derivatives of chondroitin sulfate, dermatan sulfate and hyaluronic acid and their pharmaceutical properties | |
FI814230L (en) | THERAPEUTIC AND DIAGNOSTIC COMPOSITORS AND THERAPEUTIC COMPOSITION WITH BACTERIAL INFECTION | |
US4029793A (en) | Synergistic local anesthetic compositions | |
SU1697756A1 (en) | Method for treating laryngeal diseases with persistent nonclosure of vocal folds | |
ATE85809T1 (en) | PRODUCTION OF HUMAN VON WILLEBRAND FACTOR BY RECOMBINANT DNA. | |
Jernelöv et al. | Adaptation to an acid environment in Chironomus riparius (Diptera, Chironomidae) from Smoking Hills, NWT, Canada | |
GB1483837A (en) | Polypeptide hormone | |
KR890000428A (en) | Novel 2-pyrazoline derivatives and therapeutic agents for cerebrovascular diseases containing the same | |
KR890013178A (en) | Human Colony Stimulator | |
JPS6237007B2 (en) | ||
KR890012942A (en) | 5-substituted ornithine derivatives | |
JPS5513742A (en) | Aromatic polyamide film and its production | |
JPS6354386A (en) | Phospholipid and use thereof | |
KR850005065A (en) | Herbal form for oral administration of sulfide | |
Martin et al. | Purification and characterization of eight toxins from the Brazilian scorpion Tityus serrulatus | |
JPS57106611A (en) | Coating remedy | |
Golman et al. | Metrizamide in Experimental Urography: I. Iodine Concentration and Flow of Urine following Intravenous Injection of an Ionic and a Non-Ionic Contrast Medium in Rabbits | |
KR910009723A (en) | 4-carbamoyl-1-β-D-ribofuranosyl imidazolium-5-oleate anhydrous crystals | |
KR910000600A (en) | Propanolamine derivatives | |
Wu | CHARACTERISTICS OF BOVINE INTRAMUSCULAR COLLAGEN UNDER VARIOUS POSTMORTEM CONDITIONS. | |
GB1382427A (en) | Composition and method for strengthening nails |